{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:22Z","timestamp":1786119142368,"version":"build-2736575974"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/aco.0b013e32832c5269","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T03:34:41Z","timestamp":1246851281000},"page":"496-501","source":"Crossref","is-referenced-by-count":24,"title":["Levosimendan in perioperative and critical care patients"],"prefix":"10.1097","volume":"22","author":[{"given":"Markku","family":"Salmenper\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ahj.2006.10.043","article-title":"Epidemiology and risk stratification in acute heart failure","volume":"155","author":"Fonarow","year":"2008","journal-title":"Am Heart J"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ALN.0b013e31816725ef","article-title":"Impact of heart failure on patients undergoing major noncardiac surgery","volume":"108","author":"Hammill","year":"2008","journal-title":"Anesthesiology"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1213\/01.ane.0000256864.75206.6d","article-title":"Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application? [comment]","volume":"104","author":"Pagel","year":"2007","journal-title":"Anesth Analg"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FJC.0b013e3180986230","article-title":"The cardioprotective effects of levosimendan: preclinical and clinical evidence","volume":"50","author":"Pollesello","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/ACO.0b013e3282f357a5","article-title":"Levosimendan: current status and future prospects","volume":"21","author":"Archan","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ACO.0b013e3282f43c56","article-title":"Role of levosimendan in sepsis and septic shock","volume":"21","author":"Pinto","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.107.134940","article-title":"Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs","volume":"325","author":"Masutani","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000043245.00859.11","article-title":"Sustained hemodynamic effects of intravenous levosimendan","volume":"107","author":"Kivikko","year":"2003","journal-title":"Circulation"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/01.ane.0000256863.92050.d3","article-title":"The effects of levosimendan in cardiac surgery patients with poor left ventricular function","volume":"104","author":"De Hert","year":"2007","journal-title":"Anesth Analg"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00005344-200404000-00011","article-title":"Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart","volume":"43","author":"Kaheinen","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit Care Med"},{"key":"R12-8-20210129","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1378\/chest.128.4.2633","article-title":"Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study","volume":"128","author":"Dernellis","year":"2005","journal-title":"Chest"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.107.722868","article-title":"Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis","volume":"117","author":"Jorgensen","year":"2008","journal-title":"Circulation"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bjp.2008.52","article-title":"A role for the RISK pathway and K(ATP) channels in pre and postconditioning induced by levosimendan in the isolated guinea pig heart","volume":"154","author":"du Toit","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.athoracsur.2008.10.029","article-title":"Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function","volume":"87","author":"Eriksson","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/bja\/aen367","article-title":"Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery","volume":"102","author":"Tritapepe","year":"2009","journal-title":"Br J Anaesth"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0091270008325150","article-title":"Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study","volume":"49","author":"Kleber","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.jvca.2008.02.019","article-title":"A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction","volume":"22","author":"De Hert","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1017\/S0265021508004080","article-title":"Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair","volume":"25","author":"Ponschab","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01707662","article-title":"Intra-operative gut mucosal hypoperfusion is associated with increased postoperative complications and cost","volume":"20","author":"Mythen","year":"1994","journal-title":"Intensive Care Med"},{"key":"R21-8-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.CCM.0000150653.89451.6F","article-title":"Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs","volume":"33","author":"Schwarte","year":"2005","journal-title":"Crit Care Med"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","article-title":"Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs","volume":"119","author":"Pagel","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1399-6576.2008.01659.x","article-title":"Effects of levosimendan on indocyanine green plasma disappearance rate and the gastric mucosal-arterial pCO2 gradient in abdominal aortic aneurysm surgery","volume":"52","author":"Leppikangas","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"R24-8-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1540-8191.2007.00486.x","article-title":"Levosimendan effect on spinal cord ischemia\u2013reperfusion injury following aortic clamping","volume":"23","author":"Katircioglu","year":"2008","journal-title":"J Card Surg"},{"key":"R25-8-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000121394","article-title":"Protection of the spinal cord from ischemia: comparative effects of levosimendan and iloprost","volume":"41","author":"Lafci","year":"2008","journal-title":"Eur Surg Res"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1540-8191.2007.00523.x","article-title":"Levosimendan for ischemic preconditioning in thoracic aortic aneurysm repair","volume":"23","author":"Ersoy","year":"2008","journal-title":"J Card Surg"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/01.CCM.0000266683.64081.02","article-title":"Mechanisms of sepsis-induced cardiac dysfunction","volume":"35","author":"Rudiger","year":"2007","journal-title":"Crit Care Med"},{"key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/00003246-200111000-00022","article-title":"Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock","volume":"29","author":"Oldner","year":"2001","journal-title":"Crit Care Med"},{"key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/01.CCM.0000261889.18102.84","article-title":"Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone","volume":"35","author":"Barraud","year":"2007","journal-title":"Crit Care Med"},{"key":"R30-8-20210129","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/CCM.0b013e31817cede9","article-title":"Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock","volume":"36","author":"Fries","year":"2008","journal-title":"Crit Care Med"},{"key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000539-200001000-00003","article-title":"Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels","volume":"90","author":"Kersten","year":"2000","journal-title":"Anesth Analg"},{"key":"R32-8-20210129","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/CCM.0b013e3181743e63","article-title":"Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury","volume":"36","author":"Boost","year":"2008","journal-title":"Crit Care Med"},{"key":"R33-8-20210129","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00134-005-2619-z","article-title":"Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression","volume":"31","author":"Morelli","year":"2005","journal-title":"Intensive Care Med"},{"key":"R34-8-20210129","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/01.CCM.0000230244.17174.4F","article-title":"Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study","volume":"34","author":"Morelli","year":"2006","journal-title":"Crit Care Med"},{"key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17482940701358564","article-title":"Early and sustained haemodynamic improvement with levosimendan compared to intraaortic balloon counterpulsation (IABP) in cardiogenic shock complicating acute myocardial infarction","volume":"10","author":"Christoph","year":"2008","journal-title":"Acute Card Care"},{"key":"R36-8-20210129","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/CCM.0b013e3181810446","article-title":"Levosimendan in cardiogenic shock: better than enoximone! [comment]","volume":"36","author":"Buerke","year":"2008","journal-title":"Crit Care Med"},{"key":"R37-8-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-149-5-200809020-00028","article-title":"Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome","volume":"149","author":"De Santis","year":"2008","journal-title":"Ann Intern Med"},{"key":"R38-8-20210129","first-page":"182","article-title":"Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator dependent intensive care patients","volume":"10","author":"Sterba","year":"2008","journal-title":"Crit Care Resusc"},{"key":"R39-8-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1164\/rccm.200805-732OC","article-title":"Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease","volume":"179","author":"van Hees","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R40-8-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijcard.2006.11.171","article-title":"Peripartum cardiomyopathy: a new successful setting for levosimendan","volume":"123","author":"Benezet-Mazuecos","year":"2008","journal-title":"Int J Cardiol"},{"key":"R41-8-20210129","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1399-6576.2006.01034.x","article-title":"Beneficial outcome after prostaglandin-induced postpartum cardiac arrest using levosimendan and extracorporeal membrane oxygenation","volume":"50","author":"Krumnikl","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"key":"R42-8-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1213\/ane.0b013e3181931737","article-title":"Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer","volume":"108","author":"Varpula","year":"2009","journal-title":"Anesth Analg"},{"key":"R43-8-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF03160973","article-title":"Levosimendan does not improve survival time in a rat model of verapamil toxicity","volume":"5","author":"Abraham","year":"2009","journal-title":"J Med Toxicol"},{"key":"R44-8-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15563650701665092","article-title":"Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity","volume":"46","author":"Graudins","year":"2008","journal-title":"Clin Toxicol (Phila)"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACO.0b013e32832c5269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:51:31Z","timestamp":1786038691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001503-200908000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e32832c5269","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}